Browsing index pages (3 articles)
↧
The Joint Corp. sets aggressive expansion plan
Fresh from a $20-million IPO in November, The Joint Corp. (NASDAQ:JYNT), a franchisor of some 236 chiropractic clinics in 25 states, plans to more than double the number of clinics in its chain as part...
View ArticleTearLab, Dipexium and Joint in Feltl 2015 Top Idea List
TearLab (NASDAQ:TEAR; TSX:TLB), Dipexium Pharmaceuticals (NASDAQ:DPRX) and The Joint Corp. (NASDAQ:JYNT) were included in Feltl & Co.’s 2015 Top Idea List released today. Analyst Ben Haynor rates...
View ArticleFeltl starts The Joint Corp. at strong buy
Feltl has initiated coverage of The Joint Corp. (NASDAQ:JYNT) with a “strong buy” rating and price target of $12.45. The stock closed at $6.40 on Thursday. “The Joint is poised to further disrupt the...
View Article
Browsing index pages (3 articles)